Affluent Medical | Finanzwire

PRESS RELEASE

published on 07/15/2024 at 07:45, 2 years 3 months ago

Affluent Medical announces the availability of a prospectus for the admission to trading of 6,190,831 shares issued as part of a capital increase without preferential subscription rights in favour of
Affluent Medical announces a capital increase without preferential subscription rights involving the trading of 6,190,831 shares. Edwards Lifesciences becomes a 9.21% shareholder after subscribing for €5 million. Risk factors are highlighted in the available prospectus

Capital Increase Affluent Medical Prospectus Risk Factors Trading Shares
BRIEF

published on 07/12/2024 at 07:50, 2 years 3 months ago

Affluent Medical enters into agreements on its mitral valve technologies for 15 million euros

Investment Affluent Medical Edwards Life Sciences Mitral Valve Technology Financial Agreements
PRESS RELEASE

published on 07/12/2024 at 07:45, 2 years 3 months ago

Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences, focusing on innovative medical devices and structural heart products

Affluent Medical Agreements Edwards Lifesciences Mitral Valve Technologies EUR 15M
PRESS RELEASE

published on 07/12/2024 at 07:45, 2 years 3 months ago

Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment.
Affluent Medical signs agreements with EUR 15M upfront payment for mitral valve technologies with Edwards Lifesciences. CEO expresses pride in partnership

Partnership Affluent Medical Edwards Lifesciences Mitral Valve Technologies EUR 15M Upfront Payment
BRIEF

published on 07/09/2024 at 17:50, 2 years 3 months ago

Affluent Medical: Number of shares making up the share capital and total number of voting rights as of 06/30/24

Voting Rights Actions AMF Regulation Affluent Medical
BRIEF

published on 07/09/2024 at 17:50, 2 years 3 months ago

Half-year review of Affluent Medical's liquidity contract

Liquidity Contract Transactions Kepler Cheuvreux Affluent Medical Half-yearly Review
BRIEF

published on 06/18/2024 at 17:50, 2 years 4 months ago

Affluent Medical Achieves Clinical Objective with Artus Device

Affluent Medical Clinical Study Urinary Incontinence Artus Device Medical Device Market
PRESS RELEASE

published on 06/18/2024 at 17:45, 2 years 4 months ago

Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter
Affluent Medical achieves clinical objective of Dry pilot study in first two patients with Artus artificial urinary sphincter, marking successful activation and ease of implantation. Company progresses towards goal of study

Medical Device Affluent Medical Urinary Incontinence Dry Pilot Study Artus Artificial Urinary Sphincter
PRESS RELEASE

published on 06/18/2024 at 17:45, 2 years 4 months ago

Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter.
Affluent Medical successfully activates Artus artificial urinary sphincter in first two patients, addressing global incontinence need. Read more about the innovative medical device here

Medical Device Affluent Medical Clinical Study Urinary Incontinence Artus
BRIEF

published on 06/14/2024 at 17:50, 2 years 4 months ago

Affluent Medical: Number of shares making up the share capital and total number of voting rights as of 05/30/24

Voting Rights Euronext Actions AMF Affluent Medical

Published on 10/30/2026 at 23:35, 2 days 7 hours ago

Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 2 days 7 hours ago

Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 2 days 10 hours ago

CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 2 days 12 hours ago

Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 2 days 15 hours ago

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

View all ACCESSWIRE

Published on 11/02/2026 at 07:05, 23 minutes ago

Lazard Completes Its Acquisition of Campbell Lutyens and Launches Lazard CL, the Global Leader for the Next Era of Private Capital
Published on 11/02/2026 at 07:05, 23 minutes ago

PolyPeptide Group: Provisional end result of the public tender offer of Samsung Biologics Co., Ltd.
Published on 11/02/2026 at 07:00, 28 minutes ago

Arbonia adjusts outlook for 2026 and continues to expect solid development
Published on 11/02/2026 at 07:00, 28 minutes ago

Medartis reports accelerating US momentum on faster adoption of TOUCH® thumb joint prosthesis
Published on 11/02/2026 at 07:00, 28 minutes ago

Infracore SA: Infracore gives a binding commitment in the event that the Wetzikon Hospital composition agreement fails

View all EQS

Published on 10/30/2026 at 23:00, 2 days 8 hours ago

BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 20:42, 2 days 10 hours ago

TINC and PMV invest in Storm Group (B)
Published on 10/30/2026 at 18:00, 2 days 13 hours ago

2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 12:00, 2 days 19 hours ago

Capital increase through exercise of subscription rights
Published on 10/30/2026 at 08:45, 2 days 22 hours ago

Share buyback

View all LES ECHOS COMFI WIRE

News